Tag: Eli Lilly and Co

Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment

Trump tariff fallout: Some industries grapple with lingering effects one year later

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

Eli Lilly opposes push to pass Trump’s drug pricing deals into law, CEO says

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

Stocks soar on hopes of Iran war resolution — plus, Lilly takes a big swing in sleep disorders

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly

Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market